[{"Assets_0_Q2_USD":251902000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.125,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.325,"EarningsPerShareBasic_1_Q2_USD":0.22,"EarningsPerShareBasic_2_Q2_USD":0.37,"EarningsPerShareDiluted_1_Q2_USD":0.22,"EarningsPerShareDiluted_2_Q2_USD":0.37,"NetIncomeLoss_1_Q2_USD":9312000.0,"NetIncomeLoss_2_Q2_USD":15591000.0,"StockholdersEquity_0_Q2_USD":170828000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":42568000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":42539000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":42202000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":42177000.0,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20170510"}]